Mentored Patient-Oriented Research Career Development Aw
Mentored Patient-Oriented Research Career Development Aw
批准号:
6754479
负责人:
RICHARD E ROTHMAN
金额:
$11.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2005-06-30
关键词:
bacterial diseasebacterial endocarditiscareerclinical researchdata collection methodology /evaluationdiagnostic testsdisease /disorder proneness /riskdrug abuseechocardiographyemergency health servicesendocarditishealth care cost /financinghospital length of stayhospital utilizationhuman subjecthuman therapy evaluationintravenous administrationlongitudinal human studymathematicsmedical complicationmycosisoutcomes researchpolymerase chain reactionprognosistissue /cell culture
中文摘要
建议(改编自申请人的摘要):IE是最
与静脉吸毒相关的严重医学并发症,
在未被发现的病例中发生严重的发病率和死亡率。
目前与IE相关的临床特征很难定义。
由于注射吸毒者中近98%的IE病例发生发热,
呼吁所有发热的注射吸毒者住院接受进一步评估。 的
这项研究的总体目标是开发和实施一个安全和成本-
有效的急诊科(艾德)为基础的算法,用于评估
有IE风险的发热IDUs。 研究人员假设,
最新发展的优势,它结合了联合收割机的先进发现,
诊断测试(包括超声心动图)和临床评估,
算法将使艾德医生能够更快速、更可靠地分层
有IE风险的患者。 他们进一步假设,
已排除艾德的患者子集,资源密集程度较低
设置将减少住院次数,而不会增加不良反应
活动,从而促进更有效地利用临床资源。 测试
根据这些假设,他们提出了一个由三个具体目标组成的计划:
1)推导出一种算法,使艾德医生能够预测
增加的速度和特异性,
IE或出现需要住院治疗的IE相关并发症。 标准
临床、实验室和影像学信息以及新的实验室-
的诊断工具将被用来推导算法。 2)到
确定“机会成本”(即,资源的价值,
回收并可用于其他用途)
普遍住院治疗。 3)执行和进行全面的
衍生临床算法的成本效益分析。 这项研究将
采用前瞻性的两阶段设计。 在第一阶段,备选方案
将在根据以下标准治疗的患者中对模型进行比较和评价:
普遍住院的标准做法。 第二阶段,患者
将进行评估,并出院到三个可能的设置:
随访、模拟艾德观察单位或住院治疗(如有指征)
通过临床算法。 他们将估计算法对
成本和患者的结果。 这项研究的结果将提供
可用于指导和改进评价的宝贵信息,
管理越来越多的发热注射吸毒者。
英文摘要
PROPOSAL (Adapted from the applicant's abstract): IE is one of the most
serious medical complications associated with intravenous drug use, with
significant morbidity and mortality occurring in unrecognized cases.
Presenting clinical features associated with IE have been difficult to define.
Since fever occurs in nearly 98% of cases of IE in IDUs, current practice
calls for hospitalization of all febrile IDUs for further evaluation. The
overall goal of this study is to develop and implement a safe and cost-
effective emergency department (ED)-based algorithm for the evaluation of
febrile IDUs at risk for IE. The investigators hypothesize that, by taking
advantage of recent developments which combine findings from advanced
diagnostic testing (including echocardiography) and clinical assessment, this
algorithm will enable ED physicians to more quickly and reliably stratify
patients at risk for IE. They further hypothesize that disposition of the
subset of patients in whom ED has been ruled out to less resource-intensive
settings will reduce the number of hospitalizations without increasing adverse
events, thus promoting more efficient use of clinical resources. To test
these hypotheses, they propose a program consisting of three specific aims:
1) To derive an algorithm that will allow ED physicians to predict with
increased speed and specificity which febrile IDUs are likely to either have
IE or develop IE-related complications that require hospitalization. Standard
clinical, laboratory and imaging information as well as a novel laboratory-
based diagnostic tool will be utilized to derive the algorithm. 2) To
determine the 'opportunity costs' (i.e., the value of resources that would be
recovered and available for other uses) associated with the current practice
of universal hospitalization. 3) To implement and conduct a comprehensive
cost effectiveness analysis of the derived clinical algorithm. The study will
employ a prospective, two-phase design. In the first phase, alternative
models will be compared and evaluated among patients treated according to the
standard practice of universal hospitalization. In the second phase, patients
will be evaluated and discharged to three possible settings: home with
follow-up, a simulated ED observational unit, or hospitalization, as indicated
by the clinical algorithm. They will estimate the impact of the algorithm on
costs and patients' outcomes. Findings from this research will provide
valuable information that can be used to guide and improve evaluation and
management of the growing number of febrile IDUs.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Zinc protoporphyrin IX binds heme crystals to inhibit the process of crystallization in Plasmodium falciparum.
锌原卟啉 IX 与血红素晶体结合,抑制恶性疟原虫的结晶过程。
DOI:
10.2119/2003-00010.sullivan
发表时间:
2003
期刊:
Molecular medicine (Cambridge, Mass.)
影响因子:
--
作者:
[Iyer,JayasreeK, Shi,Lirong, Shankar,AnurajH, SullivanJr,DavidJ]
通讯作者:
SullivanJr,DavidJ
Universal nucleic acid amplification tests-Diagnostics Hub1
-
批准号:8233369
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2011
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Universal nucleic acid amplification tests-Diagnostics Hub1
-
批准号:7670015
-
项目类别:
-
资助金额:$33.51万
-
财政年份:2009
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Diagnostics
-
批准号:7678801
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2008
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Bench-to-Bedside: Identification of Predictive Biomarkers of Asthma Exacerbation
-
批准号:7696967
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2007
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Bench-to-Bedside: Identification of Predictive Biomarkers of Asthma Exacerbation
-
批准号:7696966
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2007
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Mentored Patient-Oriented Research Career Development Aw
-
批准号:6394871
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2000
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Mentored Patient-Oriented Research Career Development Aw
-
批准号:6535157
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2000
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Mentored Patient-Oriented Research Career Development Aw
-
批准号:6637866
-
项目类别:
-
资助金额:$11.23万
-
财政年份:2000
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Mentored Patient-Oriented Research Career Development Aw
-
批准号:6160144
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2000
-
负责人:RICHARD E ROTHMAN
-
依托单位:
ALTERNATIVE APPROACHES FOR EVALUATION OF FEVER IN IDUS
-
批准号:2653451
-
项目类别:
-
资助金额:$6.25万
-
财政年份:1997
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Universal nucleic acid amplification tests-Diagnostics Hub1
-
批准号:8037608
-
项目类别:
-
资助金额:$34.81万
-
财政年份:--
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Universal nucleic acid amplification tests-Diagnostics Hub1
-
批准号:8442362
-
项目类别:
-
资助金额:$29.24万
-
财政年份:--
-
负责人:RICHARD E ROTHMAN
-
依托单位:
Universal nucleic acid amplification tests-Diagnostics Hub1
-
批准号:8375140
-
项目类别:
-
资助金额:$33.8万
-
财政年份:--
-
负责人:RICHARD E ROTHMAN
-
依托单位:
海外基金